Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Rifomycin S
2. Rifampicin S
| Molecular Weight | 822.9 g/mol |
|---|---|
| Molecular Formula | C43H58N4O12 |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 5 |
| Exact Mass | 822.40512330 g/mol |
| Monoisotopic Mass | 822.40512330 g/mol |
| Topological Polar Surface Area | 217 A^2 |
| Heavy Atom Count | 59 |
| Formal Charge | 0 |
| Complexity | 1750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 6 | |
|---|---|
| Drug Name | Rifadin |
| PubMed Health | Rifampin (Injection) |
| Drug Classes | Antitubercular |
| Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Sanofi Aventis Us |
| 2 of 6 | |
|---|---|
| Drug Name | Rifampin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
| 3 of 6 | |
|---|---|
| Drug Name | Rimactane |
| PubMed Health | Rifampin |
| Drug Classes | Antitubercular |
| Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 300mg |
| Market Status | Prescription |
| Company | Prosam Labs |
| 4 of 6 | |
|---|---|
| Drug Name | Rifadin |
| PubMed Health | Rifampin (Injection) |
| Drug Classes | Antitubercular |
| Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Sanofi Aventis Us |
| 5 of 6 | |
|---|---|
| Drug Name | Rifampin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
| 6 of 6 | |
|---|---|
| Drug Name | Rimactane |
| PubMed Health | Rifampin |
| Drug Classes | Antitubercular |
| Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 300mg |
| Market Status | Prescription |
| Company | Prosam Labs |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-12
Pay. Date : 2013-01-22
DMF Number : 13383
Submission : 1998-09-01
Status : Active
Type : II
Registration Number : 218MF10388
Registrant's Address : Via Angelo Titi, 22/26, Zona ex punto franco, 72100 Brindisi, Italy
Initial Date of Registration : 2006-03-20
Latest Date of Registration :
NDC Package Code : 82297-101
Start Marketing Date : 1973-04-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : ASMF |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2000-337 - Rev 03
Issue Date : 2005-02-18
Type : TSE
Substance Number : 52
Status : Withdrawn by Holder
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38768
Submission : 2023-09-29
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-04
Pay. Date : 2013-09-26
DMF Number : 13663
Submission : 1998-09-01
Status : Active
Type : II
NDC Package Code : 52972-0026
Start Marketing Date : 1998-11-16
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Chong Kun Dang Bio Co., Ltd.
Registration Date : 2009-01-30
Registration Number : 20090130-103-F-36-01
Manufacturer Name : Chong Kun Dang Bio Co., Ltd._x000D_
Manufacturer Address : B-Block Complex 16 (425-100), 454, 486 Moknae-dong, Danwon-gu, Ansan-si, Gyeonggi-do (368-3, Chungjeong-ro 3-ga, Seodaemun-gu, Seoul (120-756))

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13214
Submission : 1998-04-30
Status : Active
Type : II
Date of Issue : 2026-01-01
Valid Till : 2028-09-10
Written Confirmation Number : WC-0201
Address of the Firm :
NDC Package Code : 57297-444
Start Marketing Date : 1998-04-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2009-10-27
Registration Number : 20091027-103-F-48-03
Manufacturer Name : Lupin Limited,
Manufacturer Address : India, T-142, MIDC, Tarapur, Via Boisar, Maharashtra 401 506

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13796
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : CEP 2009-275 - Rev 06
Issue Date : 2026-02-18
Type : Chemical
Substance Number : 52
Status : Valid
Date of Issue : 2022-09-16
Valid Till : 2025-09-08
Written Confirmation Number : WC-0197
Address of the Firm :
NDC Package Code : 73005-0006
Start Marketing Date : 2022-07-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2022-05-13
Pay. Date : 2022-03-29
DMF Number : 36879
Submission : 2022-04-04
Status : Active
Type : II
Date of Issue : 2022-09-16
Valid Till : 2025-09-08
Written Confirmation Number : WC-0197
Address of the Firm :

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13717
Submission : 1998-09-01
Status : Inactive
Type : II

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13398
Submission : 1998-09-01
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
About the Company : EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API player with a portfolio o...
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...
About the Company : Anwita Drugs is a technocrat-driven pharmaceutical company with over 28 years of expertise in designing and developing solid oral dosage forms (OSD), nutraceuticals, and dietary su...

About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...

About the Company : Bills Biotech. Is an R&D driven biotechnological company that manufactures Active Pharmaceutical Ingredients through the process of Fermentation, Semi-synthetic and synthetic proce...

About the Company : CALYX is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, with its manufacturing facility located in Tarapur, Maharashtra (India). The site has been su...

About the Company : Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing p...

About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...

About the Company : Otto Brandes Gmbh was founded in 1923 and is an independent distributor of high quality Pharmaceutical Active Ingredients and excipients for the pharmaceutical industry. We regard ...

About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Isoniazid; Pyrazinamide; Rifampin
Brand Name : Rifater
Dosage Form : Isoniazid+Pyrazinamide+Rifampicin 50+300+120Mg 40 Combined Oral Use
Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 2% 60Ml Oral Use
Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 450Mg 8 Joined' Oral Use
Dosage Strength : 8 cpr riv 450 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifinah
Dosage Form : Rifampicin+Isoniazid+150300 Mg 24 Units Of Oral Use
Dosage Strength : 24 cpr riv 300 mg + 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rifinah
Dosage Form : Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 18/09/1975
Application Number : 38931
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG; 300MG
Packaging :
Approval Date : 2007-08-08
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG; 150MG
Packaging :
Approval Date : 2011-03-14
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 300MG; 150 MG
Packaging :
Approval Date : 01-09-1978
Application Number : 54213
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Capsule
Dosage Strength : 300MG
Packaging :
Approval Date : 01-06-1968
Application Number : 46029
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Powder And Solvent For Infusion Solution
Dosage Strength : 600MG
Packaging :
Approval Date : 01-03-1986
Application Number : 56487
Regulatory Info : Authorized
Registration Country : Spain
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Isoniazid; Pyrazinamide; Rifampicin
Dosage Form : Isoniazid+Pyrazinamide+Rifampici...
Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg
Price Per Pack (Euro) : 10.57
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 2% 60Ml Oral Use
Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup
Price Per Pack (Euro) : 2.8
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 300Mg 8 Joined' Oral ...
Dosage Strength : 8 cps 300 mg
Price Per Pack (Euro) : 3.72
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 450Mg 8 Joined' Oral ...
Dosage Strength : 8 cpr riv 450 mg
Price Per Pack (Euro) : 4.86
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 600Mg 1 Unit Parenter...
Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml
Price Per Pack (Euro) : 9.28
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin+Isoniazid+150300 Mg 2...
Dosage Strength : 24 cpr riv 300 mg + 150 mg
Price Per Pack (Euro) : 9.48
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
CAS Number : 13983-13-6
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : R0800000
Batch No : 4
Price (€) : 79
Storage : +5°C ± 3°C

CAS Number : 13292-46-1
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : R0700000
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
38
PharmaCompass offers a list of Rifampicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rifampicin manufacturer or Rifampicin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifampicin manufacturer or Rifampicin supplier.
A RFP manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RFP, including repackagers and relabelers. The FDA regulates RFP manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RFP API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of RFP manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A RFP supplier is an individual or a company that provides RFP active pharmaceutical ingredient (API) or RFP finished formulations upon request. The RFP suppliers may include RFP API manufacturers, exporters, distributors and traders.
click here to find a list of RFP suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A RFP DMF (Drug Master File) is a document detailing the whole manufacturing process of RFP active pharmaceutical ingredient (API) in detail. Different forms of RFP DMFs exist exist since differing nations have different regulations, such as RFP USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A RFP DMF submitted to regulatory agencies in the US is known as a USDMF. RFP USDMF includes data on RFP's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The RFP USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of RFP suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The RFP Drug Master File in Japan (RFP JDMF) empowers RFP API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the RFP JDMF during the approval evaluation for pharmaceutical products. At the time of RFP JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of RFP suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a RFP Drug Master File in Korea (RFP KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of RFP. The MFDS reviews the RFP KDMF as part of the drug registration process and uses the information provided in the RFP KDMF to evaluate the safety and efficacy of the drug.
After submitting a RFP KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their RFP API can apply through the Korea Drug Master File (KDMF).
click here to find a list of RFP suppliers with KDMF on PharmaCompass.
A RFP CEP of the European Pharmacopoeia monograph is often referred to as a RFP Certificate of Suitability (COS). The purpose of a RFP CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of RFP EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of RFP to their clients by showing that a RFP CEP has been issued for it. The manufacturer submits a RFP CEP (COS) as part of the market authorization procedure, and it takes on the role of a RFP CEP holder for the record. Additionally, the data presented in the RFP CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the RFP DMF.
A RFP CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. RFP CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of RFP suppliers with CEP (COS) on PharmaCompass.
A RFP written confirmation (RFP WC) is an official document issued by a regulatory agency to a RFP manufacturer, verifying that the manufacturing facility of a RFP active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting RFP APIs or RFP finished pharmaceutical products to another nation, regulatory agencies frequently require a RFP WC (written confirmation) as part of the regulatory process.
click here to find a list of RFP suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing RFP as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for RFP API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture RFP as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain RFP and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a RFP NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of RFP suppliers with NDC on PharmaCompass.
RFP Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of RFP GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right RFP GMP manufacturer or RFP GMP API supplier for your needs.
A RFP CoA (Certificate of Analysis) is a formal document that attests to RFP's compliance with RFP specifications and serves as a tool for batch-level quality control.
RFP CoA mostly includes findings from lab analyses of a specific batch. For each RFP CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
RFP may be tested according to a variety of international standards, such as European Pharmacopoeia (RFP EP), RFP JP (Japanese Pharmacopeia) and the US Pharmacopoeia (RFP USP).